Study demonstrates Resveratrol’s ability to mitigate Alzheimer’s Disease (AD) symptoms by inhibiting proinflammatory responses and promoting antioxidant enzyme expression in microglial cell lines, offering insights into its neuroprotective mechanisms.
Verano Holdings Q1 Sales Grow 1% Sequentially
Verano Announces First Quarter 2023 Financial Results Company Capitalizes on Strength of Recently-Converted Adult Use Markets to Deliver Revenue of $227 Million, a 12% Year-Over-Year
May 10, 2023